Femcare's £3.6M Acquisition of Orion Medical Supplies Adds ~$6M Annual Revenue to UTMD
UTMD sits 33% above its 52-week low of $53.66.
Summary
Femcare, UTMD's UK subsidiary, acquired Orion Medical Supplies for £3.6 million, adding about $6 million in annual revenue and a stable, profitable niche business in harm-reduction devices.
Key Events · M&A and Partnerships · UTMD
-
Acquisition of Orion Medical Supplies
Femcare Ltd, UTMD's wholly-owned UK subsidiary, purchased all common shares of Orion Medical Supplies Ltd for £3.6 million, funded entirely from cash reserves.
-
Revenue Accretion
Orion is expected to add approximately $6 million to UTMD's consolidated annual sales, significantly offsetting the 14% revenue decline reported in Q2 2026.
-
Operational Integration
Orion's operations will be relocated to Femcare's existing Romsey facilities, leveraging infrastructure to reduce overhead as a percentage of UK sales.
-
Strategic Diversification
Orion distributes harm-reduction medical devices to the NHS and European organizations—a stable, non-synergistic niche with geographic expansion potential.
Analysis · UTMD · Industrial Applications And Services
Femcare, the UK subsidiary of Utah Medical Products, has acquired Orion Medical Supplies—a niche distributor of harm-reduction devices—for £3.6 million in cash. The deal is expected to add roughly $6 million to annual sales, a meaningful lift given that UTMD's revenue fell 14% in Q2 to $8.53 million after losing two large customers. While the acquisition is accretive and leverages Femcare's existing infrastructure, the product line is not synergistic with UTMD's core medical devices. This strategic diversification move partially offsets recent revenue declines.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTMD was trading at $71.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $227.2M. The 52-week trading range was $53.66 to $75.75. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.